Occlusion of PFO with a dedicated adjustable device: Influence on one year outcome

EuroIntervention

Volumn 6, Issue 3, 2010, Pages 367-370

  Kleber, Franz Xaver ^a   Winkelmann, Anne ^a   Stretz, Anna ^a   Sonntag, Steffen Mark ^a   Bruch, Leonhard ^a   Rademacher, Grit ^a   Sparenberg, Paul ^a   Schmehl, Ingo ^a  

^a Academic Teaching Hospital   (Germany)

Author keywords

Dedicated PFO closure system; Patent foramen ovale; Residual shunt; Transcatheter closure of PFO

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CLIP; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; PATENT FORAMEN OVALE; PATIENT SAFETY; RECURRENCE RISK; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; COMPARATIVE STUDY; FOLLOW UP; MIDDLE AGED; PROSTHESIS; RETROSPECTIVE STUDY; SEPTAL OCCLUDER; STROKE; TIME;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; FORAMEN OVALE, PATENT; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; SEPTAL OCCLUDER DEVICE; STROKE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79952195730     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV6I3A61     Document Type: Article

References (18)

1. Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, Drobinski G, Thomas D, Grosgogeat Y. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988;318:1148-1152.
2. Webster MW, Chancellor AM, Smith HJ, Swift DL, Sharpe DN, Bass NM, Glasgow GL. Patent foramen ovale in young stroke patients. Lancet 1988;2:11-12.
3. Mugge A, Daniel WG, Angermann C, Spes C, Khandheria BK, Kronzon I, Freedberg RS, Keren A, Denning K, Engberding R, Sutherland GR, Vered Z, Erbel R., Visser, CA, Lindert O, Hausmann, D, Wenzlaff P. Arterial septal aneurysm in adult patients. A multicenter study using transthoracic and transesophageal echocardiography. Circulation 1995;91:2785-2792.
4. Lamy C, Giannesini C, Zuber M, Arquizan C, Meder JF, Trystram D, Coste J, Mas JL. Clinical and Imaging Findings in Cryptogenic Stroke Patients With and Without Patent Foramen Ovale: The PFO-ASA Study. Stroke 2002;33:706-711
5. Schuchlenz HW, Saurer G, Weihs W, Rehak P. Persisting eustachian valve in Adults: relation to patent foramen ovale and cerebrovascular events. J Am Soc Echocardiogr. 2004;17:231-233.
6. Karttunen V, Hiltunen L, Rasi V, Vahtera E, Hillbom M. Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale. Blood Coagul Fibrinolysis 2003;14:261-268.
7. Botto N, Spadoni I, Giusti S, Ait-Ali L, Sicari R, Andreassi MG. Prothrombotic mutations as risk factors for cryptogenic ischemic cerebrovascular events in young subjects with patent foramen ovale. Stroke 2007;38:2070-2073.
8. Büscheck F, Sievert H, Kleber F, Tiefenbacher C, Krumsdorf U, Windecker S, Uhlemann F, Wahr DW. Patent foramen ovale using the Premere device: the results of the CLOSEUP trial. J Interv Cardiol. 2006;19:328-333.
9. Dorenbeck U, Simon B, Skowasch D, Stüsser C, Gockel A, Schild HH, Urbach H, Bauriedel G. Cerebral embolism with interventional closure of symptomatic patent foramen ovale: an MRI-based study using diffusion-weighted imaging. Eur J Neurol. 2007;14:451-454.
10. Dubiel M, Bruch L, Liebner M, Schmehl I, Winkelmann A, Rux S, Sonntag S, Grad MO, Kleber FX. Exclusion of Patients with Arteriosclerosis Reduces Long-Term Recurrence Rate of Presumed Arterial Embolism after PFO Closure. J Interv Cardiol. 2007;20:275-281. (Pubitemid 47228552)
11. Bruch L, Parsi A, Grad MO, Rux S, Burmeister T, Krebs H, Kleber FX. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism: single-center experience. Circulation 2002;105:2845-2848. (Pubitemid 34666096)
12. Slotto TL, Steinberg DH, Waksman R. Overview of the 2007 Food and Drug Administration Circulatory System Devices Panel Meeting on Patent Foramen Ovale Closure Devices. Circulation 2007;116:677-682.
13. Wahl A MD, Praz F, Stirnimann J MD, Windecker S MD, Seiler C MD, Nedeltchev K MD, Mattle HP MD, Meier B MD. Safety and Feasibility of Percutaneous Closure of Patent Foramen Ovale Without Intra-Procedural Echocardiography in 825 Patients. Swiss Medical Weekly 2008.
14. Wahl A, Kunz M, Moschovitis A, Nageh T, Schwerzmann M, Seiler C, Mattle HP, Windecker S, Meier B. Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxil embolism. Heart 2008;94:336-341. Epub 2007 Jul 16.
15. Luermann JG, Post MC, Schräder R, Sluysmans T, Vydt T, Vermeersch P, Chessa M, Onorato E, Goy JJ, Budts WI. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study. Cath Cardiov Interv. 2008;71:822-828.
16. Hung J, Landzberg MJ, Jenkins KJ, King ME, Lock JE, Palacios IF, Lang P. Closure of patent foramen ovale for paradoxical emboli: intermediate- term. J Am Coll Cardiol 2000;35:1311-1316.
17. Sievert H, Horvath K, Zadan E, Krumsdorf U, Fach A, Merle H, Scherer D, Schrader R, Spies H, Nowak B, Lissmann-Jensen H. Patent foramen ovale closure in patients with transient ischemic attack/stroke. J Interv Cardiol. 2001;14:261-266.
18. Martin F, Sanchez PL, Doherty E, Colon-Hernandez PJ, Delgado G, Inglessis I, Scott N, Hung J, King JMEE, Buonanno F, Demirjian Z, de Moor M, Palacios IF, Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation 2002;106:1121-1126.